These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4281879)

  • 21. [Renal effects of aldosterone and spironolactone in rats f different age].
    Bräunlich H; Kersten L
    Acta Biol Med Ger; 1972; 28(1):73-80. PubMed ID: 5048187
    [No Abstract]   [Full Text] [Related]  

  • 22. [Regulation of renin secretion in saluretic-induced sodium loss].
    Zehner J; Ebel H; Klaus D; Witzgall H
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():210-1. PubMed ID: 613576
    [No Abstract]   [Full Text] [Related]  

  • 23. Re-evaluation of the role of aldosterone in mechanism of natriuresis induced by extracellular fluid volume expansion.
    Turek R; Ponec J; Brlicová A; Lichardus B
    Endocrinol Exp; 1976; 10(4):253-7. PubMed ID: 1087225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of spironolactone on aldosterone regulation in man.
    Gaillard RC; Riondel AM; Chabert P; Vallotton MB
    Clin Sci (Lond); 1980 Mar; 58(3):227-33. PubMed ID: 6244912
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism.
    Ulmann A; Bertagna C; Le Go A; Husson JM; Tache A; Sassano P; Menard J; Corvol P
    Eur J Clin Pharmacol; 1985; 28(5):531-5. PubMed ID: 3899674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of aldosterone and spirolactone on renal sodium and potassium excretion during mannitol diuresis.
    Nagasaka M; Nakamura K; Kinouchi T; Kurosawa T; Ito T
    Jpn Heart J; 1968 Jan; 9(1):3-12. PubMed ID: 5301394
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of hydrochlorothiazide, spironolactone and metyrapone on electrolyte excretion and zona glomerulosa width in the sodium depleted rat.
    Hofmann LM; Sagartz JW
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):76-84. PubMed ID: 5470027
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of aldosterone blockade during fasting and refeeding.
    Boulter PR; Spark RF; Arky RA
    Am J Clin Nutr; 1973 Apr; 26(4):397-402. PubMed ID: 4712416
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of furosemide on calciuria].
    Pecchini F; Andreucci VE; Savi M
    G Clin Med; 1967 Feb; 48(2):191-200. PubMed ID: 5601208
    [No Abstract]   [Full Text] [Related]  

  • 31. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute changes in plasma volume (PV), plasma renin activity (PRA) and plasma aldosterone concentration in healthy persons following natriuresis and diuresis induced by furosemide].
    Rosenthal J; Boucher R; Nowaczynsky W; Genest J
    Verh Dtsch Ges Inn Med; 1968; 74():423-6. PubMed ID: 5714356
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of saluretics on the excretion of aldosterone and electrolytes in normal pregnancy].
    Stark G; Müller C
    Arch Gynakol; 1967; 204(1):16-27. PubMed ID: 5630693
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reaction of premature infants and infants on the sodium and volume depletion].
    Janovský M; Chromá M; Popp M; Martínek J
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):293-4. PubMed ID: 5523662
    [No Abstract]   [Full Text] [Related]  

  • 36. Aldosterone and postprandial renal excretion of sodium and potassium in sheep.
    Rabinowitz L; Denham SC; Gunther RA
    Am J Physiol; 1977 Sep; 233(3):F213-6. PubMed ID: 910916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modification of ionic balance by an injectable antialdosterone drug in resuscitation].
    Roquefeuil B; Nord D; Viguie E; Fischbach C
    Agressologie; 1972; 13(3):185-94. PubMed ID: 5086033
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
    Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of diuretic and antidiuretic properties of furosemide in diabetes insipidus.
    Radó JP; Bános C; Marosi J; Borbély L; Takó J
    Endokrinologie; 1968; 53(3):253-60. PubMed ID: 5713386
    [No Abstract]   [Full Text] [Related]  

  • 40. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.